光热治疗
自噬
免疫疗法
热休克蛋白90
细胞内
材料科学
热休克蛋白
生物物理学
癌症研究
纳米技术
纳米颗粒
细胞生物学
转染
癌症免疫疗法
光热效应
免疫原性细胞死亡
细胞
膜
化学
聚乙二醇化
伴侣(临床)
细胞膜
肿瘤细胞
免疫系统
嵌合体(遗传学)
免疫
体内
药物输送
热休克蛋白70
Hsp90抑制剂
人工细胞
融合蛋白
程序性细胞死亡
细胞毒性
癌症治疗
作者
Xiaohui Liu,Shurong Qin,Lu Wang,Wen Luo,Dongtao Zhou,Yuhan Zhao,Junhui Gu,Ruiyue Chen,Bangshun He,Yuzhen Wang,Yi Bing Yin,Yujun Song
摘要
ABSTRACT Therapeutic barriers and resistance limit the efficacy of immunotherapy in metastatic breast cancer. Here, we report a dual‐nanobody autophagy‐targeting chimera (AUTAC), hereafter referred to as Nb, that selectively degrades heat shock protein 90 (HSP90) via p62‐dependent autophagy, restoring tumor sensitivity to immunogenic cell death (ICD). To construct the delivery nanoplatform, Nb was preassembled into protein‐polymer nanoparticles (Nb‐PC), coated with cholesterol‐depleted 4T1 tumor cell membranes (Nb‐PC@M), and further decorated with citrate‐stabilized Pd nanoparticles (Pd NPs) to obtain Nb‐PC@MPd. This hierarchical design integrates reversible protein‐polymer assembly, biomimetic membrane coating, and asymmetric Pd anchoring. In vivo, Nb‐PC@MPd achieves EPR‐ and membrane‐assisted tumor accumulation, followed by NIR‐assisted intratumoral Nb delivery and intracellular Nb release, promotes p62‐dependent HSP90 autophagic degradation, and potentiates mild photothermal therapy (mPTT)‐induced ICD. Consequently, Nb‐PC@MPd elicits systemic antitumor immunity and effectively suppresses both tumor growth and pulmonary metastasis. This platform integrates programmable protein degradation, biomimetic thermophoretic delivery, and tumor‐directed immunomodulation, providing a versatile strategy for precision macromolecular therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI